Viking Therapeutics, Inc. · NASDAQ:VKTX
BlackRock, Inc. reported a 5.30% stake in Viking Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 4, 2025
BlackRock, Inc. reported a 5.30% stake in Viking Therapeutics, Inc., 5,872,642 shares, as a passive investor on Dec 31, 2024. Filed Feb 4, 2025 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 5,872,642
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.30% | 5,872,642 |
Source
Related
- Viking Therapeutics, Inc.
- BlackRock, Inc.
- Viking Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 23, 2025
- Form 4 · Kelly-Gemmell Dorothy Elizabeth · Aug 7, 2026
- Form 4 · Lian Brian · Jul 29, 2026
- Form 4 · Zante Greg · Jul 29, 2026
- Form 4 · Mancini Marianna · Jul 29, 2026
- Schedule 13G · Vanguard Capital Management LLC · Apr 30, 2026